VSMD — Vasamed Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Vasamed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.07 | 1.39 | 2 | 3.13 | 3.13 |
| Cost of Revenue | |||||
| Gross Profit | -0.32 | -0.069 | 0.382 | 1.34 | 1.73 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.36 | 6.13 | 6.89 | 6.97 | 5.87 |
| Operating Profit | -6.3 | -4.74 | -4.88 | -3.84 | -2.73 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -6.42 | -6.85 | -6.48 | -5.63 | -2.92 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.69 | -1.82 | -1.68 | -0.703 | -0.365 |
| Dividends per Share |